CeriBell Inc (CBLL): רווח נקי למניה (EPS TTM)

CeriBell, Inc. (CBLL) is independently scaling its diagnostic systems across clinics, bypassing mergers. Revenues are based on SaaS subscriptions and the sale of the Rapid Response EEG cloud service. Growth is supported by alliances with intensive care units to implement AI monitoring. Rolling trailing twelve-month earnings per share illustrate the stock's price action, where -1.94 characterizes this valuation parameter.

Net income per share (TTM) is calculated by dividing the total annual net income by the total number of outstanding securities, reflecting the actual portion of profit attributable to a single share of ownership. For CeriBell, Inc., which is scaling AI diagnostics across US hospitals, the rolling earnings per share trend serves as an indicator of equipment expansion efficiency and subscription monetization.